Depression and Parkinson's Disease: Current Knowledge

被引:259
作者
Marsh, Laura [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Neurol, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA
关键词
Depression; Parkinson's disease; Mood disorder; Psychiatric; Antidepressant; Cognitive behavioral therapy; Electroconvulsive therapy; Quality of life; Treatment; Suicide; Major depression: dysthymia; Minor depression; Subsyndromal depression; Epidemiology; Pathophysiology; COGNITIVE-BEHAVIORAL THERAPY; TRANSCRANIAL MAGNETIC STIMULATION; SEROTONIN TRANSPORTER GENE; DOUBLE-BLIND; NONMOTOR SYMPTOMS; CONTROLLED-TRIAL; ANXIETY DISORDERS; ALLELIC VARIATION; FOLLOW-UP; PLACEBO;
D O I
10.1007/s11910-013-0409-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Depressive disturbances are common in patients with Parkinson's disease (PD) and influence many other clinical aspects of the disease. In addition to causing inherent emotional distress, depressive disorders negatively impact quality of life, motor and cognitive deficits, functional disability, and other psychiatric comorbidities in patients with PD. Knowledge of the pathophysiology of PD depression remains limited. However, clinical studies demonstrate the efficacy of medications and psychotherapies for PD depression, underscoring the importance of their timely detection and concerted management.
引用
收藏
页数:9
相关论文
共 103 条
[1]   Depression in Parkinson disease-epidemiology, mechanisms and management [J].
Aarsland, Dag ;
Pahlhagen, Sven ;
Ballard, Clive G. ;
Ehrt, Uwe ;
Svenningsson, Per .
NATURE REVIEWS NEUROLOGY, 2012, 8 (01) :35-47
[2]   Neuropsychiatric Symptoms in Parkinson's Disease [J].
Aarsland, Dag ;
Marsh, Laura ;
Schrag, Anette .
MOVEMENT DISORDERS, 2009, 24 (15) :2175-2186
[3]   Executive dysfunction and the course of geriatric depression [J].
Alexopoulos, GS ;
Kiosses, DN ;
Heo, M ;
Murphy, CF ;
Shanmugham, B ;
Gunning-Dixon, F .
BIOLOGICAL PSYCHIATRY, 2005, 58 (03) :204-210
[4]  
ANDERSEN J, 1980, ACTA NEUROL SCAND, V62, P210
[5]   Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease [J].
Arabia, Gennarina ;
Grossardt, Brandon R. ;
Geda, Yonas E. ;
Carlin, Justin M. ;
Bower, James H. ;
Ahlskog, J. Eric ;
Maraganore, Demetrius M. ;
Rocca, Walter A. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (12) :1385-1392
[6]   Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients [J].
Arbouw, Maurits E. L. ;
Movig, Kris L. L. ;
Neef, Cees ;
Guchelaar, Henk-Jan ;
Egberts, Toine C. G. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (02) :181-187
[7]   Cognitive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review [J].
Armento, Maria E. A. ;
Stanley, Melinda A. ;
Marsh, Laura ;
Kunik, Mark E. ;
York, Michele K. ;
Bush, Amber L. ;
Calleo, Jessica S. .
JOURNAL OF PARKINSONS DISEASE, 2012, 2 (02) :135-151
[8]   Pramipexole versus sertraline in the treatment of depression in Parkinson's disease - A national multicenter parallel-group randomized study [J].
Barone, Paolo ;
Scarzella, Leonardo ;
Marconi, Roberto ;
Antonini, Angelo ;
Morgante, Letterio ;
Bracco, Fulvio ;
Zappia, Mario ;
Musch, Bruno .
JOURNAL OF NEUROLOGY, 2006, 253 (05) :601-607
[9]   Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial [J].
Barone, Paolo ;
Poewe, Werner ;
Albrecht, Stefan ;
Debieuvre, Catherine ;
Massey, Dan ;
Rascol, Olivier ;
Tolosa, Eduardo ;
Weintraub, Daniel .
LANCET NEUROLOGY, 2010, 9 (06) :573-580
[10]   Transient acute depression induced by high-frequency deep-brain stimulation [J].
Bejjani, BP ;
Damier, P ;
Arnulf, I ;
Thivard, L ;
Bonnet, AM ;
Dormont, D ;
Cornu, P ;
Pidoux, B ;
Samson, Y ;
Agid, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (19) :1476-1480